Current status of adoptive immunotherapy of malignancies

Author： Morse Michael A   Clay Timothy M   Lyerly H Kim  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.3, 2002-03, pp. : 237-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enhancing adoptive immunotherapy of cancer

By Westwood Jennifer A   Berry Linda J   Wang Leanne XJ   Duong Connie PM   Pegram Hollie J   Darcy Phillip K   Kershaw Michael H  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. : 531-545

Informa Healthcare

Access to resources Recommend Favorite

Adoptive T cell immunotherapy for cytomegalovirus

By Peggs Karl S  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 6, 2009-06 ,pp. : 725-736

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy for gynaecological malignancies

By Coukos George   Conejo-Garcia Jose R   Roden Richard BS   Wu T-C  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 9, 2005-09 ,pp. : 1193-1210

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy for gastrointestinal cancer: current status and strategies for improving efficacy

By Elkord Eyad   Hawkins Robert E   Stern Peter L  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 385-395

Informa Healthcare

Access to resources Recommend Favorite

Natural killer: can they be useful as adoptive immunotherapy for cancer?

By Arai Sally   Klingemann Hans-G  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 2, 2005-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite